19462052|t|Exploiting a (13)C-labelled heparin analogue for in situ solid-state NMR investigations of peptide-glycan interactions within amyloid fibrils.
19462052|a|Pathological amyloid deposits are mixtures of polypeptides and non-proteinaceous species including heparan sulfate proteoglycans and glycosaminoglycans (GAGs). We describe a procedure in which a (13)C-labelled N-acetyl derivative of the GAG heparin ([(13)C-CH(3)]NAcHep) serves as a useful probe for the analysis of GAG-protein interactions in amyloid using solid-state nuclear magnetic resonance (SSNMR) spectroscopy. NAcHep emulates heparin by enhancing aggregation and altering the fibril morphology of Abeta(1-40), one of the beta-amyloid polypeptides associated with Alzheimer's disease, and alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease. (13)C SSNMR spectra confirm the presence of [(13)C-CH(3)]NAcHep in Abeta(1-40) fibril deposits and detect dipolar couplings between the glycan and arginine R(5) at the Abeta(1-40) N-terminus, suggesting that the two species are intimately mixed at the molecular level. This procedure provides a foundation for further extensive investigations of polypeptide-glycan interactions within amyloid fibrils.
19462052	13	18	(13)C	Chemical	MESH:C000615229
19462052	28	35	heparin	Chemical	MESH:D006493
19462052	99	105	glycan	Chemical	MESH:D011134
19462052	126	133	amyloid	Disease	MESH:C000718787
19462052	156	172	amyloid deposits	Disease	MESH:D058225
19462052	276	294	glycosaminoglycans	Chemical	MESH:D006025
19462052	296	300	GAGs	Chemical	MESH:D006025
19462052	338	343	(13)C	Chemical	MESH:C000615229
19462052	353	361	N-acetyl	Chemical	-
19462052	380	383	GAG	Chemical	MESH:D006025
19462052	384	391	heparin	Chemical	MESH:D006493
19462052	393	412	[(13)C-CH(3)]NAcHep	Chemical	-
19462052	459	462	GAG	Chemical	MESH:D006025
19462052	487	494	amyloid	Disease	MESH:C000718787
19462052	562	568	NAcHep	Chemical	-
19462052	578	585	heparin	Chemical	MESH:D006493
19462052	715	734	Alzheimer's disease	Disease	MESH:D000544
19462052	740	755	alpha-synuclein	Gene	6622
19462052	788	799	Lewy bodies	Disease	MESH:D020961
19462052	816	835	Parkinson's disease	Disease	MESH:D010300
19462052	837	842	(13)C	Chemical	MESH:C000615229
19462052	881	900	[(13)C-CH(3)]NAcHep	Chemical	-
19462052	973	979	glycan	Chemical	MESH:D011134
19462052	1195	1201	glycan	Chemical	MESH:D011134
19462052	1222	1229	amyloid	Disease	MESH:C000718787
19462052	Association	MESH:D011134	MESH:C000718787
19462052	Association	MESH:C000615229	MESH:D006493
19462052	Association	MESH:D006025	MESH:C000718787
19462052	Association	MESH:C000615229	MESH:D006025
19462052	Association	MESH:D010300	6622
19462052	Association	MESH:D006025	MESH:D058225
19462052	Association	MESH:D020961	6622
19462052	Association	MESH:D006493	MESH:C000718787

